Cencora director buys 4,000 shares in open market

Cencora, Inc. director Dermot Mark Durcan reported an open-market purchase of company stock.

Rhea-AI Filing Summary

Cencora, Inc. director Dermot Mark Durcan reported an open-market purchase of company stock. On June 18, 2026, he bought 4,000 shares of Cencora common stock at $274.19 per share. After this transaction, he directly holds 31,767 common shares of the company.

Insights

Equity governance analyst

Director made a sizable open-market share purchase, increasing direct holdings.

A director of Cencora, Inc., Dermot Mark Durcan, executed an open-market purchase of 4,000 shares of common stock at $274.19 per share. Open-market purchases are discretionary transactions, distinct from automatic grants or tax-related movements.

Following the transaction, he directly owns 31,767 shares of common stock, with no derivative positions listed in this filing. The Form 4 reflects a net buy of 4,000 shares, and there are no accompanying sales, gifts, or restructurings disclosed in this report.

Insider Trade Summary

Net Buyer: 4,000 shares

Net Buy 1 txn

Insider DURCAN DERMOT MARK

Role Director

Bought 4,000 shs ($1.10M)

Type	Security	Shares	Price	Value
Purchase	Common Stock	4,000	$274.19	$1.10M

Holdings After Transaction: Common Stock — 31,767 shares (Direct)

Key Figures

Shares purchased: 4,000 shares Purchase price: $274.19 per share Shares held after transaction: 31,767 shares +1 more

4 metrics

Shares purchased 4,000 shares Open-market purchase of Cencora common stock

Purchase price $274.19 per share Price paid in the June 18, 2026 transaction

Shares held after transaction 31,767 shares Director’s direct Cencora common stock holdings post-trade

Net buy shares 4,000 shares Net change in buy/sell activity in this Form 4

Key Terms

open-market purchase, Common Stock, Form 4

3 terms

open-market purchase financial

"he bought 4,000 shares of Cencora common stock in an open-market purchase"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"executed an open-market purchase of 4,000 shares of Cencora common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"according to the Form 4 filing for June 18, 2026"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cencora (COR) director Dermot Mark Durcan report in this Form 4?

Director Dermot Mark Durcan reported buying 4,000 shares of Cencora common stock in an open-market transaction at $274.19 per share. After this purchase, his direct ownership rose to 31,767 common shares, according to the Form 4 filing.

Was the Cencora (COR) insider transaction a purchase or a sale?

The reported Cencora transaction was a purchase. Dermot Mark Durcan executed an open-market purchase of 4,000 shares of common stock, coded “P” on Form 4, with no corresponding sales or dispositions disclosed in this filing.

How many Cencora (COR) shares does the director hold after the reported trade?

After the reported trade, director Dermot Mark Durcan directly holds 31,767 shares of Cencora common stock. This total reflects his position immediately following the 4,000-share open-market purchase disclosed in the Form 4 filing for June 18, 2026.

At what price did the Cencora (COR) director buy shares in this Form 4?

The director’s open-market purchase was executed at an average price of $274.19 per share. He acquired 4,000 Cencora common shares at this price, as detailed in the Form 4, increasing his total direct holdings to 31,767 shares.

Does the Cencora (COR) Form 4 show any derivative securities or option exercises?

The Form 4 shows no derivative securities or option-related transactions. The filing reports only a single non-derivative transaction: an open-market purchase of 4,000 shares of Cencora common stock, with derivative positions listed as an empty summary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DURCAN DERMOT MARK

(Last) (First) (Middle)

1 WEST FIRST AVENUE

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2026		P		4,000	A	$274.19	31,767	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Elizabeth S. Campbell, attorney-in-fact for D. Mark Durcan	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)